Investors
Overview
Medicure was founded in 1997 and became a public company in November 1999. The company trades under the symbol MPH on the TSX Venture Exchange. As a U.S focused Specialty Pharma company with established sales of Aggrastat, Medicure carefully monitors opportunities within its own pipeline of products and possible acquisitions of related pharma companies in order to realize long term value.
Corporate Presentation
Investor Presentation
Conference Call
Financial Reports
Quarterly and Annual financial reports will be posted below after release.
Effective Dec 18, 2014 the Fiscal Year End was changed to December 31 from May 31.
Edgar and SEDAR filings for Medicure can be found on their respected websites.
Financial Reports for 2018
Q3 - September 30, 2018
Q2 - June 30, 2018
Q1 - March 31, 2018
Financial Reports for 2017
Q4 - December 31, 2017
Q3 - Septemeber 30, 2017
Q2 - June 30, 2017
Q1 - March 31, 2017
Financial Reports for 2016
Q4 and Year End - April 26, 2017
Q3 - September 30, 2016
Q2 - June 30, 2016
Q1 - March 31, 2016
Financial Reports for 2015
Q4 and Year End - December 31, 2015
Q3 - September 30, 2015
Q2 - June 30, 2015
Q1 - March 31, 2015
Financial Reports for 2014
7 Months Ended Dec 31, 2014
Q1 - Aug 31, 2014
Fiscal 2014 - May 31, 2014
Q3 - Feb 28, 2014
Financial Reports for 2013
Q2 - Nov 30, 2013
Q1 - Aug 31, 2013
Fiscal 2013 - May 31, 2013
Q3 - Feb 28, 2013
Financial Reports for 2012
Q2 - Nov 30, 2012
Q1 - Aug 31, 2012
Fiscal 2012 - May 31, 2012
Q3 - Feb 29, 2012
Financial Reports for 2011
Q2 - Nov 30, 2011
Q1 - Aug 31, 2011
Fiscal 2011 - May 31, 2011
Q3 - Feb 28, 2011
